EP Patent

EP1543831A1 — Pregabalin composition

Assigned to Pfizer GmbH · Expires 2005-06-22 · 21y expired

What this patent protects

The application comprises a stable liquid Pregabalin preparation that is adjusted to a stable pH-range below 6,5 and above 5,5, preferably below 6,2 and above 5,8. The liquid preparation of Pregabalin is preserved by a combination of methyl- and ethyl-parabene in a w/v ratio of 3…

USPTO Abstract

The application comprises a stable liquid Pregabalin preparation that is adjusted to a stable pH-range below 6,5 and above 5,5, preferably below 6,2 and above 5,8. The liquid preparation of Pregabalin is preserved by a combination of methyl- and ethyl-parabene in a w/v ratio of 3:1 to 5:1. The preparation also comprises saccharin-sodium as a sweetening agent and flavouring agents lacking aldehyde- or keto-functions.

Drugs covered by this patent

Patent Metadata

Patent number
EP1543831A1
Jurisdiction
EP
Classification
Expires
2005-06-22
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.